Lower dose radiotherapy did not alter cardiac function and was not pro-arrhythmic: results of the small prospective HALO trial

Back

EHRA Premium Access

Lower dose radiotherapy did not alter cardiac function and was not pro-arrhythmic: results of the small prospective HALO trial

Session: Ventricular tachycardia 3

Topic: Radiotherapy

Speaker: Mr W. Hoeksema (Amsterdam, NL)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Mr Wiert Hoeksema

Amsterdam (Netherlands (The))

0 follower

8 more presentations in this session

Modification of deceleration zones and late potentials after ventricular tachycardias substrate ablation

Speaker: Doctor P. China (Mestre-Venice, IT)

An optimized multisource acquisition and registration workflow for imaging guided ventricular tachycardia ablation

Speaker: Doctor M. Parollo (Pisa, IT)

The evaluation of the efficacy of automated peak frequency annotation algorithm for the identification of critical isthmus of ventricular tachycardia and deceleration zones

Speaker: Professor H. Yorgun (Ankara, TR)

Genotype, phenotype and outcomes of patients with hypertrophic cardiomyopathy referred for ablation of ventricular tachycardia

Speaker: Doctor A. Meretta (Leiden, NL)

Characterization of ventricular tachycardia ablation in end-stage heart failure patients with left ventricular assist device (CHANNELED-Registry)

Speaker: Doctor J. van den Bruck (Cologne, DE)

Access the full session

Ventricular tachycardia 3

Speakers: Mr W. Hoeksema, Doctor P. China, Doctor M. Parollo, Professor H. Yorgun, Doctor A. Meretta...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources